Who owns Fulcrum Therapeutics Inc?
- Ticker: FULC
- CUSIP Number: 359616109
Tip: Access positions for across all investors
Analyze quarterly positions in Fulcrum Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Fulcrum Therapeutics stock
Who bought or sold Fulcrum Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 12M | $110M | 0% | Mar 2024 |
|
| FMR | 5.4M | $51M | -10% | Mar 2024 |
|
| Cowen And Company | 3.7M | $35M | 7% | Mar 2024 |
|
| Suvretta Capital Management | 2.8M | $27M | -50% | Mar 2024 |
|
| Vanguard Group | 2.5M | $24M | 1% | Mar 2024 |
|
| Trv Gp Iv | 2.3M | $22M | 0% | Mar 2024 |
|
| Caption Management | 1.8M | $17M | 100% | Mar 2024 |
|
| BlackRock | 1.5M | $15M | 7% | Mar 2024 |
|
| Citadel Advisors | 1.4M | $13M | -21% | Mar 2024 |
|
| Dimensional Fund Advisors | 1.3M | $12M | 34% | Mar 2024 |
|
| Morgan Stanley | 1.2M | $11M | 27% | Mar 2024 |
|
| Leucadia National Corporation | 1.2M | $11M | -20% | Mar 2024 |
|
| MPM Oncology Impact Management | 1.1M | $11M | 100% | Mar 2024 |
|
| Adage Capital Partners GP | 1.1M | $10M | -54% | Mar 2024 |
|
| Logos Global Management | 1.0M | $9.4M | -17% | Mar 2024 |
|
| Millennium Management | 898k | $8.5M | 105% | Mar 2024 |
|
| Susquehanna International | 886k | $8.4M | -9% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 823k | $7.8M | 0% | Mar 2024 |
|
| Goldman Sachs Group | 810k | $7.6M | -7% | Mar 2024 |
|
| Propel Bio Management | 750k | $7.1M | 0% | Mar 2024 |
|
| Rock Springs Capital Management | 728k | $6.9M | 0% | Mar 2024 |
|
| Qube Research & Technologies | 723k | $6.8M | 5435% | Mar 2024 |
|
| Simplify Asset Management | 676k | $6.4M | 20% | Mar 2024 |
|
| D. E. Shaw & Co | 625k | $5.9M | 26% | Mar 2024 |
|
| Geode Capital Management | 564k | $5.3M | 5% | Mar 2024 |
|
| Jane Street | 535k | $5.1M | 54% | Mar 2024 |
|
| Two Sigma Advisers | 420k | $4.0M | -15% | Mar 2024 |
|
| ADAR1 Capital Management | 340k | $3.2M | -47% | Mar 2024 |
|
| Bessemer | 287k | $1.9M | 0% | Dec 2023 |
|
| Standard Life Aberdeen | 257k | $2.4M | 0% | Mar 2024 |
|
| Alliancebernstein | 240k | $1.6M | 3% | Dec 2023 |
|
| Marshall Wace | 226k | $2.1M | -55% | Mar 2024 |
|
| Point72 Asset Management | 223k | $2.1M | 100% | Mar 2024 |
|
| Partners HealthCare System | 205k | $1.9M | 100% | Mar 2024 |
|
| Alyeska Investment Group | 202k | $1.9M | 0% | Mar 2024 |
|
| Citigroup | 179k | $1.6M | -37% | Mar 2024 |
|
| Two Sigma Investments | 175k | $1.7M | -33% | Mar 2024 |
|
| Cubist Systematic Strategies | 172k | $1.6M | 100% | Mar 2024 |
|
| Susquehanna Portfolio Strategies | 169k | $1.6M | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 159k | $1.5M | 1289% | Mar 2024 |
|
| Cibc World Markets | 150k | $1.4M | 100% | Mar 2024 |
|
| Laurion Capital Management | 145k | $1.4M | 0% | Mar 2024 |
|
| Rbf Capital | 140k | $1.3M | -9% | Mar 2024 |
|
| Fiduciary Trust Company | 137k | $922k | 0% | Dec 2023 |
|
| Northern Trust | 136k | $1.3M | -5% | Mar 2024 |
|
| Opaleye Management | 130k | $1.2M | 0% | Mar 2024 |
|
| Hrt Financial | 123k | $1.2M | 100% | Mar 2024 |
|
| Man Group | 102k | $965k | 8% | Mar 2024 |
|
| Landscape Capital Management | 95k | $895k | 46% | Mar 2024 |
|
| American Century Companies | 92k | $870k | 150% | Mar 2024 |
|
| Point72 Asia | 90k | $845k | 100% | Mar 2024 |
|
| Bridgeway Capital Management | 89k | $836k | -30% | Mar 2024 |
|
| Brevan Howard Capital Management | 89k | $835k | 100% | Mar 2024 |
|
| Stifel Financial | 85k | $803k | 19% | Mar 2024 |
|
| Commonwealth Equity Services | 83k | $788k | -13% | Mar 2024 |
|
| Squarepoint Ops | 75k | $705k | 100% | Mar 2024 |
|
| UBS Group | 73k | $687k | 141% | Mar 2024 |
|
| Barclays | 72k | $666k | 5% | Mar 2024 |
|
| Bank of America Corporation | 62k | $582k | -67% | Mar 2024 |
|
| DekaBank Deutsche Girozentrale | 60k | $568k | 0% | Mar 2024 |
|
| Wolverine Trading | 59k | $558k | 67% | Mar 2024 |
|
| Y-Intercept | 54k | $514k | 100% | Mar 2024 |
|
| HAP Trading | 50k | $120k | 100% | Mar 2024 |
|
| PDT Partners | 50k | $467k | 100% | Mar 2024 |
|
| Marathon Trading Investment Management | 45k | $425k | 100% | Mar 2024 |
|
| Centiva Capital | 43k | $407k | 100% | Mar 2024 |
|
| ALPS Advisors | 40k | $269k | 100% | Dec 2023 |
|
| Acuitas Investments | 33k | $314k | -75% | Mar 2024 |
|
| Mirae Asset Global Investments | 33k | $308k | 100% | Mar 2024 |
|
| Simplex Trading | 31k | $290k | 100% | Mar 2024 |
|
| Country Trust Bank | 30k | $285k | 0% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 29k | $275k | -93% | Mar 2024 |
|
| Denali Advisors | 27k | $256k | -53% | Mar 2024 |
|
| Brandywine Managers | 26k | $247k | 0% | Mar 2024 |
|
| Algert Coldiron Investors | 26k | $174k | -17% | Dec 2023 |
|
| Brown Wealth Management | 25k | $236k | 0% | Mar 2024 |
|
| Franklin Resources | 25k | $234k | 0% | Mar 2024 |
|
| Charles Schwab Investment Management | 25k | $231k | 0% | Mar 2024 |
|
| ExodusPoint Capital Management | 21k | $202k | 100% | Mar 2024 |
|
| Group One Trading | 21k | $197k | 208% | Mar 2024 |
|
| Jacobs Levy Equity Management | 21k | $193k | -83% | Mar 2024 |
|
| Blackstone Group | 19k | $181k | 0% | Mar 2024 |
|
| Polymer Capital Management | 19k | $178k | 100% | Mar 2024 |
|
| LMR Partners | 18k | $166k | 100% | Mar 2024 |
|
| Principal Financial Group | 16k | $153k | -10% | Mar 2024 |
|
| T. Rowe Price Associates | 16k | $151k | 0% | Mar 2024 |
|
| Balyasny Asset Management | 16k | $148k | -85% | Mar 2024 |
|
| GSA Capital Partners | 15k | $143k | 100% | Mar 2024 |
|
| CTC Alternative Strategies | 15k | $139k | 100% | Mar 2024 |
|
| Alphabet | 14k | $135k | 0% | Mar 2024 |
|
| XTX Topco | 13k | $124k | -66% | Mar 2024 |
|
| Corton Capital | 13k | $118k | 100% | Mar 2024 |
|
| SG Americas Securities | 12k | $115k | 100% | Mar 2024 |
|
| China Universal Asset Management | 12k | $113k | 67% | Mar 2024 |
|
| Capstone Investment Advisors | 11k | $103k | 9% | Mar 2024 |
|
| Tower Research Capital | 9.9k | $93k | 88% | Mar 2024 |
|
| Aquatic Capital Management | 9.0k | $85k | 114% | Mar 2024 |
|
| Fernwood Investment Management | 7.6k | $72k | 100% | Mar 2024 |
|
| Marquette Asset Management | 6.0k | $57k | -78% | Mar 2024 |
|
| PrairieView Partners | 5.0k | $48k | 0% | Mar 2024 |
|
| Zurcher Kantonalbank | 2.5k | $23k | 23% | Mar 2024 |
|
| Steward Partners Investment Advisory | 1.7k | $16k | 112% | Mar 2024 |
|
| Rhumbline Advisers | 1.7k | $16k | 0% | Mar 2024 |
|
| NISA Investment Advisors | 1.5k | $15k | 0% | Mar 2024 |
|
| BFSG | 1.2k | $11k | 100% | Mar 2024 |
|
| Quadrant Capital | 1.0k | $9.8k | 100% | Mar 2024 |
|
| National Bank Of Canada /fi/ | 460.00 | $3.3k | 0% | Dec 2023 |
|
| Wells Fargo & Company | 387.00 | $3.7k | 2% | Mar 2024 |
|
| Daiwa Securities Group | 138.00 | $1.0k | 0% | Mar 2024 |
|
| Parallel Advisors | 75.00 | $708.000000 | 70% | Mar 2024 |
|
| GAMMA Investing | 45.00 | $424.998000 | 100% | Mar 2024 |
|
| Royal Bank of Canada | 8.00 | $0 | 0% | Mar 2024 |
|
Who sold out of Fulcrum Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| ClariVest Asset Management | Sep 2023 | 104k | $464k |
| Jump Financial | Sep 2023 | 92k | $408k |
| 683 Capital Management | Dec 2023 | 47k | $316k |
| Bank of New York Mellon | Dec 2023 | 20k | $134k |
| Verition Fund Management | Sep 2023 | 19k | $85k |
| Mirabella Financial Services | Dec 2023 | 17k | $114k |
| LM Advisors | Dec 2023 | 16k | $109k |
| Bank Of Montreal | Dec 2023 | 14k | $98k |
| Sherbrooke Park Advisers | Dec 2023 | 12k | $79k |